Catalyst Pharma stops dip after CEO share purchase – Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)

0
21


Catalyst Pharmaceuticals (CPRX -3.1%) is trimming losses after the disclosure of an insider purchase from its CEO and president.

Patrick McEnany bought 10,000 shares today, according to a filing just posted.

The purchase came at a price of $4.89.





Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here